GENE ONLINE|News &
Opinion
Blog

2025-10-20| Trending

HLTH 2025 Insights: AI, Collaboration, and Healthcare’s Next Wave

by Steven Chung
Share To
“There’s No Reason We Can’t Be Educated,”Rob Lowe said. Image: HLTH USA

HLTH USA 2025 drew over 12,000 attendees to Las Vegas this year. The event ran from October 19-22. It has included more than 2,750 CEOs from across the healthcare ecosystem. HLTH is a global health innovation event. It covers key topics like AI and digital health. Discussions included diagnostics and workforce changes. Women’s health and food-as-medicine were also priorities. Patient-centered care remained a central theme this year.

AI & Emerging Tech: Make Care Delivery New Again

AI and emerging technology were major focal points. These new tools are reshaping healthcare delivery. They also improve clinical decisions and patient engagement. The venue featured a dedicated AI Transformation Zone. It also had an AI Innovation Theater. 

These areas showed real-world uses of AI. They highlighted machine learning, automation, and AR/VR. Leaders from many sectors attended these sessions. This included health systems, payers, and pharma. Startups also played a significant role. 

This shows a wide commitment to technology. The discussions moved beyond vital projects. Leaders focused on full-scale technology adoption. They talked about compliance and workflow integration. Data security was also a key topic. These insights help Asia-Pacific stakeholders adapt.

HLTH Human-Centric Health: From Nutrition to Clinician Well-being

The conference also focused on human-centric innovation. It looked beyond technology alone. Women’s health sessions tackled important issues. They covered reproductive care and menopause. They also addressed chronic disease equity. The unique Food Lab showcased nutrition science. It highlighted food-as-medicine models. 

Practitioner well-being also received great attention. Sessions addressed clinician burnout and new care models. “Patient Voice” sessions were very important. They ensured patient experiences were heard. This signals a shift toward patient-centered care. It shows a paradigm shift from treating disease. The new focus is designing systems for health.

In spite of the previous insights, In the panel discussion “The Bigger Picture: Scaling Personalized Medicine for All”, speakers emphasized again the importance of patients. “The consumer is the ultimate CEO of their health, but are we putting more burden on the patient than we should be?” Margaret Anderson, Managing Director of Deloitte, noted.

“There’s No Reason We Can’t Be Educated”: Rob Lowe on a New Era of Patient Empowerment

Hollywood icon and advocate Rob Lowe joined cancer clinical trial participant Alicia Dellario and Jacob Van Naarden, EVP & President of Lilly Oncology, to share deeply personal stories about hope, research, and the human side of innovation in cancer care.

Lowe mentioned, “The good news is there’s between AI, the internet, everything out there. There’s no reason that we all can’t be educated in ways that would have been unimaginable even five years ago.”

The conversation emphasized that clinical trials are a vital blend of care and discovery, offering participants access to investigational treatments and dedicated medical teams. However, persistent misperceptions create a significant barrier, with a low participation rate of only 7% among U.S. cancer patients. 

This highlights the urgent need for education to advance science. A powerful way to combat this is by sharing personal stories, which can change behavior by overcoming fear and increase understanding. Moreover, this approach fuels the hope that drives progress, ensuring clinical trials continue to move cancer research forward and create a path for tomorrow’s patients.

HLTH Ecosystem Collaboration: Building Healthcare’s Future Together

HLTH 2025 emphasized interaction over just innovation. It brought many different groups together. Providers, payers, and startups shared one platform. This cross-pollination was clear in the speaker lineup. 

Greg Adams of Kaiser Permanente urged bold leadership. He called for collaboration to advance health equity. Investor Sophia Bush discussed storytelling in women’s health. Dr. Jessica Shepherd of Hims & Hers highlighted inclusive care. Marc L. Boom MD from Houston Methodist shared AI strategy. Brett Taylor of SIERRA discussed healthcare data innovation. These voices show healthcare’s future. It is a networked ecosystem, not just a single-dimension solution.

Adding a powerful voice to the call for industry transformation, entrepreneur and investor Mark Cuban took the main stage at HLTH USA 2025. In a session with Zach Stafford of SiriusXM, he delivered an unfiltered challenge to the healthcare ecosystem: move beyond buzzwords and commit to tangible goals of transparency, affordability, and patient-first access. Cuban argued that entrepreneurial drive, powered by technology, is essential to reshape the industry, reduce systemic costs, and ultimately empower people to take control of their own health. His session served as a masterclass in how bold leadership and actionable vision can catalyze the collaboration needed to redefine the future of care.

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
From Pill Counter to Cancer Partner: Inside City of Hope’s Push to Make Pharmacists Central to Precision Oncology
2025-10-22
A Gateway to North American Biomedical Expansion — What Canada Offers, and How to Use It
2025-10-22
From AI to Precision Medicine: Taiwan’s Smart Healthcare Pavilion Showcases 10 Global-Ready Innovators at Taiwan Expo USA 2025
2025-08-28
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top